This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

FRANCES PASCHER, M.D.

Arch Derm Syphilol. 1950;61(6):909-912.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EXPERIENCE with calciferol (vitamin D₂) in the treatment of lupus erythematosus has been limited to a few therapeutic trials. Charpy,¹ who with Dowling² was one of the first proponents of calciferol therapy, found this agent ineffective in lupus erythematosus. Popoff and Ivanov³ likewise found calciferol of no benefit in 3 cases of lupus erythematosus of the mucous membranes.

There have been surprisingly few publications dealing with penicillin therapy of the disease, although the consensus is that penicillin is of little or no value in the management of either the acute or the chronic form of lupus erythematosus. Franks⁴ administered penicillin parenterally in 2 cases of chronic discoid lupus erythematosus. In 1 the eruption remained unchanged, and in the other the disease "became much worse, as shown by the increase in sedimentation rate and the dissemination of the lesions." Kolmer⁵ and Strakosch⁶ each obtained . . . [Full Text PDF of this Article]

Author Affiliations
BROOKLYN

From the Department of Dermatology and Syphilology of the New York University Post-Graduate Medical School, Dr. Marion B. Sulzberger, chairman, and the Skin and Cancer Unit of University Hospital.

Footnotes
This paper is the seventh in a "Symposium on Lupus Erythematosus," held at the Bronx Dermatological Society on Dec. 15, 1949.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?